These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6769935)

  • 21. Dopaminergic--GABA-ergic interaction in the nigrostriatal system.
    Koltai MZ; György L
    Acta Physiol Acad Sci Hung; 1981; 58(3):225-33. PubMed ID: 7348023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On certain relationships between gamma-aminobutyric acid (GABA) and dopaminergic agents in pentylenetetrazol convulsions.
    Roussinov KS; Lazarova MB
    Acta Physiol Pharmacol Bulg; 1978; 4(3):43-9. PubMed ID: 220842
    [No Abstract]   [Full Text] [Related]  

  • 23. Apomorphine stereotypies and transmitter mechanisms in the striatum. II. Interactions between GABA-ergic and cholinergic transmission.
    Georgiev VP; Petkova BP
    Acta Physiol Pharmacol Bulg; 1978; 4(3):65-70. PubMed ID: 220844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GABAergic agents and clonidine attenuate footshock-induced aggression in mice.
    Aley KO; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1989 Sep; 11(9):541-5. PubMed ID: 2586201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of octopamine on GABA-ergic transmission in rats.
    Jagiełło-Wójtowicz E; Chodkowska A
    Pol J Pharmacol Pharm; 1984; 36(6):595-601. PubMed ID: 6100132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of gamma-aminobutyric acid in acute and chronic neuroleptic action.
    Scheel-Krüger J; Christensen AV
    Adv Biochem Psychopharmacol; 1980; 24():233-43. PubMed ID: 6105778
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of gamma-hydroxybutyric acid, baclofen, aminooxyacetic acid, and apomorphine on dopamine turnover in corpus striatum and limbic system.
    Andén NE
    Adv Biochem Psychopharmacol; 1977; 16():495-9. PubMed ID: 18898
    [No Abstract]   [Full Text] [Related]  

  • 28. [GABA-ergic mechanisms of the cerebrovascular effects of fenazepam and diazepam].
    Gan'shina TS
    Biull Eksp Biol Med; 1980 Oct; 90(10):439-42. PubMed ID: 7426706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Muscle cramp as the result of impaired GABA function--an electrophysiological and pharmacological observation.
    Obi T; Mizoguchi K; Matsuoka H; Takatsu M; Nishimura Y
    Muscle Nerve; 1993 Nov; 16(11):1228-31. PubMed ID: 8413375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GABAergic agents-induced antinociceptive effect in mice.
    Aley KO; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1989 Oct; 11(10):597-601. PubMed ID: 2511384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of GABA-positive drugs on the background and superior sagittalis sinus-electrostimulated activity of neurons in the nucleus trigeminalis caudalis of rats].
    Sokolov AIu; Amelin AV; Ignatov IuD; Panteleev SS
    Eksp Klin Farmakol; 2008; 71(5):3-7. PubMed ID: 19093363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Action of beta(4-chlorphenyl)GABA, gamma-hydroxybutyrolactone, and apomorphine on central dopamine neurons.
    Fuxe K; Agnati L; Everitt BJ; Hökfelt T; Ljungdahl A; Perez de la Mora M
    Adv Biochem Psychopharmacol; 1977; 16():489-94. PubMed ID: 883553
    [No Abstract]   [Full Text] [Related]  

  • 33. Adrenergic and dopaminergic modulation of growth hormone and prolactin secretion in normal and tumor bearing human pituitaries in monolayer culture.
    Tallo D; Malarkey WB
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1278-84. PubMed ID: 7298804
    [No Abstract]   [Full Text] [Related]  

  • 34. The ontogenesis of GABA mediated inhibition of growth hormone release in the sheep.
    Gluckman PD
    J Dev Physiol; 1982 Aug; 4(4):227-36. PubMed ID: 7175120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential action of secreto-inhibitors on proopiomelanocortin biosynthesis in the intermediate pituitary of Xenopus laevis.
    Dotman CH; Cruijsen PM; Jenks BG; Roubos EW
    Endocrinology; 1996 Nov; 137(11):4551-7. PubMed ID: 8895316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of GABAergic drugs on ethanol-induced gastric lesions.
    de Bernardis E; Caruso A; Cutuli VM; Lucenti A; Villari L; Amico-Roxas M
    J Physiol Paris; 1993; 87(6):389-92. PubMed ID: 8292990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different control mechanisms of growth hormone (GH) secretion between gamma-amino- and gamma-hydroxy-butyric acid: neuroendocrine evidence in Parkinson's disease.
    Volpi R; Chiodera P; Caffarra P; Scaglioni A; Saccani A; Coiro V
    Psychoneuroendocrinology; 1997 Oct; 22(7):531-8. PubMed ID: 9373886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GABA-ergic mechanisms in the anticonvulsive activity of newly synthesized barbiturates. II. Correlation of HB-7 with GABA-ergic agents.
    Getova D; Georgiev V
    Acta Physiol Pharmacol Bulg; 1988; 14(2):49-55. PubMed ID: 2851914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulatory effect of acute baclofen administration on human growth hormone secretion.
    Koulu M; Lammintausta R; Dahlström S
    J Clin Endocrinol Metab; 1979 Jun; 48(6):1038-40. PubMed ID: 447793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence that GABA mechanisms mediate the anxiolytic action of benzodiazepines: a study with valproic acid.
    Lal H; Shearman GT; Fielding S; Dunn R; Kruse H; Theurer K
    Neuropharmacology; 1980 Aug; 19(8):785-9. PubMed ID: 6106907
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.